Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| classical monocyte | 4 studies | 21% ± 5% | |
| epithelial cell | 4 studies | 29% ± 10% | |
| endothelial cell | 3 studies | 24% ± 8% | |
| myeloid cell | 3 studies | 18% ± 1% | |
| erythroblast | 3 studies | 22% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 5883.44 | 1445 / 1445 | 100% | 102.46 | 183 / 183 |
| intestine | 100% | 6541.47 | 966 / 966 | 100% | 56.78 | 526 / 527 |
| skin | 100% | 4764.17 | 1809 / 1809 | 100% | 61.40 | 470 / 472 |
| ovary | 100% | 6432.37 | 180 / 180 | 100% | 65.83 | 428 / 430 |
| breast | 100% | 4683.79 | 459 / 459 | 99% | 47.40 | 1112 / 1118 |
| prostate | 100% | 5969.95 | 245 / 245 | 99% | 44.67 | 499 / 502 |
| uterus | 100% | 8016.67 | 170 / 170 | 99% | 50.11 | 456 / 459 |
| stomach | 100% | 4945.94 | 359 / 359 | 99% | 68.10 | 284 / 286 |
| lung | 100% | 5754.30 | 578 / 578 | 99% | 51.14 | 1142 / 1155 |
| bladder | 100% | 5967.00 | 21 / 21 | 99% | 44.72 | 498 / 504 |
| brain | 99% | 4027.03 | 2621 / 2642 | 100% | 52.46 | 702 / 705 |
| thymus | 100% | 5924.88 | 653 / 653 | 99% | 36.21 | 597 / 605 |
| pancreas | 100% | 2955.22 | 328 / 328 | 98% | 33.60 | 175 / 178 |
| kidney | 100% | 4186.66 | 89 / 89 | 97% | 28.22 | 870 / 901 |
| adrenal gland | 100% | 6085.36 | 258 / 258 | 94% | 29.48 | 217 / 230 |
| liver | 100% | 2860.53 | 226 / 226 | 89% | 21.42 | 361 / 406 |
| adipose | 100% | 4433.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 57.95 | 29 / 29 |
| muscle | 100% | 4609.60 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 7460.63 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 55.34 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 16.28 | 1 / 1 |
| blood vessel | 100% | 5055.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 3469.45 | 853 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 40.96 | 79 / 80 |
| peripheral blood | 92% | 3929.99 | 852 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0019046 | Biological process | release from viral latency |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0050821 | Biological process | protein stabilization |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0043254 | Biological process | regulation of protein-containing complex assembly |
| GO_0045787 | Biological process | positive regulation of cell cycle |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0035097 | Cellular component | histone methyltransferase complex |
| GO_0044545 | Cellular component | NSL complex |
| GO_0071339 | Cellular component | MLL1 complex |
| GO_0016020 | Cellular component | membrane |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0043025 | Cellular component | neuronal cell body |
| GO_0044665 | Cellular component | MLL1/2 complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0048188 | Cellular component | Set1C/COMPASS complex |
| GO_0000123 | Cellular component | histone acetyltransferase complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0140297 | Molecular function | DNA-binding transcription factor binding |
| GO_0003682 | Molecular function | chromatin binding |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
| GO_0003713 | Molecular function | transcription coactivator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | HCFC1 |
| Protein name | Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] Host cell factor C1 HCFC1 protein |
| Synonyms | HFC1 HCF1 |
| Description | FUNCTION: Transcriptional coregulator (By similarity). Involved in control of the cell cycle . Also antagonizes transactivation by ZBTB17 and GABP2; represses ZBTB17 activation of the p15(INK4b) promoter and inhibits its ability to recruit p300 . Coactivator for EGR2 and GABP2 . Tethers the chromatin modifying Set1/Ash2 histone H3 'Lys-4' methyltransferase (H3K4me) and Sin3 histone deacetylase (HDAC) complexes (involved in the activation and repression of transcription, respectively) together . Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1 . As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues . Recruits KMT2E/MLL5 to E2F1 responsive promoters promoting transcriptional activation and thereby facilitates G1 to S phase transition . Modulates expression of homeobox protein PDX1, perhaps acting in concert with transcription factor E2F1, thereby regulating pancreatic beta-cell growth and glucose-stimulated insulin secretion (By similarity). May negatively modulate transcriptional activity of FOXO3 (By similarity). .; FUNCTION: (Microbial infection) In case of human herpes simplex virus (HSV) infection, HCFC1 forms a multiprotein-DNA complex with the viral transactivator protein VP16 and POU2F1 thereby enabling the transcription of the viral immediate early genes. . |
| Accessions | ENST00000444191.5 P51610 ENST00000369984.4 Q05C05 H7C1C4 ENST00000310441.12 [P51610-1] A6NEM2 |